Consensus TransMedics Group, Inc.

Stocks

TMDX

US89377M1099

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 13:08:05 2026-08-31 EDT			5-day change	1st Jan Change
83.26 ^USD	-5.84%		-10.95%	-31.48%

08-05	UBS Adjusts Price Target on TransMedics Group to $77 From $80, Maintains Neutral Rating	MT
08-05	TransMedics Group, Inc., Q2 2026 Earnings Call, Aug 04, 2026

Evolution of the Average Target: TransMedics Group, Inc.

Evolution of the Target Price: TransMedics Group, Inc.

Changes in Analyst Recommendations: TransMedics Group, Inc.

4316a.BMRhJ_BciK04WE6XSUxWnfqefbN4LbZXyWzgp3AExDY.SrAiaJI9258JInynfzVnqrHSHv0iWtsdiCuXlUFhkHN-8CtLlxDtyEw3Fw~595420e70ba0413f861d08d8558eba89

Analysts' recommendations: TransMedics Group, Inc.

08-05	UBS Adjusts Price Target on TransMedics Group to $77 From $80, Maintains Neutral Rating	MT
07-28	UBS Initiates TransMedics Group at Neutral With $80 Price Target	MT
05-06	TransMedics Shares Drop After Oppenheimer Downgrade Following Q1 Miss	MT
05-06	Needham Adjusts Price Target on TransMedics Group to $142 From $174, Maintains Buy Rating	MT
05-06	Oppenheimer Downgrades TransMedics Group to Market Perform From Outperform	MT
04-07	TransMedics Facing 'Misplaced' Concerns Over Increasing Jet Fuel Prices, Oppenheimer Says	MT
02-25	Oppenheimer Adjusts Price Target on TransMedics to $175 From $150, Maintains Outperform Rating	MT
02-25	Needham Raises Price Target on TransMedics Group to $174 From $166, Keeps Buy Rating	MT
12-23	TransMedics Could Report Q4 Beat if it Maintains Monthly Organ Transplant Volume, Needham Says	MT
12-08	Needham Raises Price Target on TransMedics Group to $166 From $148, Keeps Buy Rating	MT
11-25	William O'Neil Initiates TransMedics Group at Buy	MT
25-10-23	TransMedics Group Shares Rise After Needham Upgrade	MT
25-10-23	Needham Upgrades TransMedics Group to Buy From Hold, Sets $148 Price Target	MT
25-10-13	Jefferies Initiates TransMedics Group at Buy With $145 Price Target	MT
25-09-04	Stifel Initiates TransMedics Group at Neutral With $115 Price Target	MT
25-07-30	TransMedics Q2 revenue beats expectations, raises FY forecast	RE
25-06-17	Oppenheimer Hikes TransMedics Group Price Target to $150 From $130, Maintains Outperform Rating	MT
25-05-13	Morgan Stanley Adjusts Price Target on TransMedics Group to $103 From $80, Maintains Equalweight Rating	MT
24-12-17	JPMorgan Downgrades TransMedics Group to Neutral From Overweight, Cuts Price Target to $75 From $116	MT
24-11-22	Needham Downgrades TransMedics Group to Hold From Buy, Removes $109 Price Target	MT
24-10-29	Needham Slashes Price Target on TransMedics Group to $109 From $208 on Slower Growth, Keeps Buy Rating	MT
24-09-24	Baird Initiates Coverage on TransMedics Group With Outperform Rating, $200 Price Target	MT
24-08-21	Needham Initiates TransMedics Group at Buy With $208 Price Target	MT
24-08-01	Oppenheimer Adjusts TransMedics Group Price Target to $200 From $125, Maintains Outperform Rating	MT
24-07-15	Piper Sandler Adjusts TransMedics Group's PT to $170 From $120, Keeps Overweight Rating	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TRANSMEDICS GROUP, INC.					+10.03%
	THERMO FISHER SCIENTIFIC, INC.					+1.49%
	DANAHER CORPORATION					+5.5%
	INTUITIVE SURGICAL, INC.					+28.29%
	BOSTON SCIENTIFIC CORPORATION					+33.84%
	EDWARDS LIFESCIENCES CORPORATION					+11.92%
	SIEMENS HEALTHINEERS AG					+14.23%
	AGILENT TECHNOLOGIES, INC.					+13.36%
	WATERS CORPORATION					+5.98%
	RESMED, INC.					+2.15%
	Average					+12.68%
	Weighted average by Cap.					+11.75%